Renal dysfunction detected by beta-2 microglobulinuria in sick neonates

Area of Science:

• Neonatal Intensive Care
• Pediatric Nephrology
• Biomarker Discovery

Background:

• Neonatal kidney injury is a significant concern in critically ill infants.
• Standard renal function tests may not detect early or subtle renal tubular damage.
• Urinary beta 2 microglobulin (B2M) is a potential biomarker for proximal tubular dysfunction.

Purpose of the Study:

• To evaluate renal involvement in sick neonates admitted to the Neonatal Intensive Care Unit (NICU).
• To assess the utility of standard renal parameters and urinary B2M excretion in identifying renal dysfunction.
• To investigate the correlation between B2M levels and specific neonatal conditions.

Main Methods:

• A descriptive study was conducted in a Level II NICU and Pediatric Tertiary hospital.
• Forty-six sick neonates and 40 healthy controls were included.
• Standard renal function tests and urinary B2M levels (measured by radioimmunoassay on days 1, 3, and 7) were analyzed.

Main Results:

• Ninety percent (41/46) of sick neonates exhibited elevated urinary B2M, indicating tubular dysfunction, while only 17% showed abnormalities on standard tests.
• Significantly high B2M levels were observed in neonates with birth asphyxia, sepsis, and congenital renal diseases.
• Transient B2M elevation occurred in meconium aspiration syndrome; persistent elevation was noted in surgical cases.

Conclusions:

• Elevated urinary B2M in 90% of sick neonates, often with normal standard renal parameters, suggests subclinical proximal tubular dysfunction.
• Urinary B2M is a sensitive indicator for detecting subtle renal tubular dysfunction in neonates, particularly those with asphyxia, sepsis, and congenital malformations.
• Further research is needed to determine the long-term clinical significance of persistent B2M elevation.